Terms: = Ovarian cancer AND NKX2-1, BCH, 7080, ENSG00000136352, P43699, TITF1, TEBP, BHC, NKX2A, TTF-1, NKX2_1, NK-2
122 results:
1. Periostin's role in uterine leiomyoma development: a mini-review on the potential periostin poses as a pharmacological intervention for uterine leiomyoma.
Kiesler ZG; Hunter MI; Balboula AZ; Patterson AL
Arch Gynecol Obstet; 2024 May; 309(5):1825-1831. PubMed ID: 38441600
[TBL] [Abstract] [Full Text] [Related]
2. ER-positive and BRCA2-mutated breast cancer: a literature review.
Li PC; Zhu YF; Cao WM; Li B
Eur J Med Res; 2024 Jan; 29(1):30. PubMed ID: 38184581
[TBL] [Abstract] [Full Text] [Related]
3. Maintenance therapy for newly and recurrent epithelial ovarian cancer: current therapies and future perspectives.
Salutari V; Giudice E; Lorusso D
Curr Opin Obstet Gynecol; 2024 Feb; 36(1):9-17. PubMed ID: 38170548
[TBL] [Abstract] [Full Text] [Related]
4. Development and validation of a predictive model of abnormal uterine bleeding associated with ovulatory dysfunction: a case-control study.
Zhang Y; Luo Z; Jia Y; Zhao Y; Huang Y; Ruan F; Ying Q; Ma L; Luo J; Zhou J
BMC Womens Health; 2023 Oct; 23(1):536. PubMed ID: 37828525
[TBL] [Abstract] [Full Text] [Related]
5. Undifferentiated component of dedifferentiated endometrial carcinoma presenting as a "small round cell" malignancy in a mediastinal lymph node, mimicking small cell carcinoma.
Balikani L; Policarpio-Nicolas MLC
Diagn Cytopathol; 2023 Aug; 51(8):519-524. PubMed ID: 37318779
[TBL] [Abstract] [Full Text] [Related]
6. Extrauterine Mesonephric-like Carcinoma: A Comprehensive Single Institution Study of 33 Cases.
Euscher ED; Marques-Piubelli ML; Ramalingam P; Wistuba I; Lawson BC; Frumovitz M; Malpica A
Am J Surg Pathol; 2023 Jun; 47(6):635-648. PubMed ID: 37026792
[TBL] [Abstract] [Full Text] [Related]
7. Mesonephric-like Endometrial Carcinoma: Results From Immunohistochemical Screening of 300 Endometrial Carcinomas and Carcinosarcomas for This Often Overlooked and Potentially Aggressive Entity.
Mills AM; Jenkins TM; Howitt BE; Fan J; Ring KL; Cook I
Am J Surg Pathol; 2022 Jul; 46(7):921-932. PubMed ID: 35195579
[TBL] [Abstract] [Full Text] [Related]
8. Clinical Approach to Neuroendocrine Neoplasm Associated With ovarian Teratoma.
Opalińska M; Sowa-Staszczak A; Olearska H; Ulatowska-Bialas M; Gilis-Januszewska A; Hubalewska-Dydejczyk A
Front Endocrinol (Lausanne); 2021; 12():770266. PubMed ID: 34917031
[TBL] [Abstract] [Full Text] [Related]
9. Mesonephric-like adenocarcinoma of the ovary in an elderly woman: A case report and a review of the literature.
Ujita M; Abiko K; Kuwahara R; Emoto I; Amano Y; Konishi I
J Obstet Gynaecol Res; 2021 Dec; 47(12):4490-4495. PubMed ID: 34580958
[TBL] [Abstract] [Full Text] [Related]
10. cancer-testis antigen ACRBP expression and serum immunoreactivity in ovarian cancer: Its association with prognosis.
Lin L; Nong W; Luo B; Ge Y; Zeng X; Li F; Fan R; Zhang Q; Xie X
Immun Inflamm Dis; 2021 Dec; 9(4):1759-1770. PubMed ID: 34528758
[TBL] [Abstract] [Full Text] [Related]
11. Distinct transcriptional programs stratify ovarian cancer cell lines into the five major histological subtypes.
Barnes BM; Nelson L; Tighe A; Burghel GJ; Lin IH; Desai S; McGrail JC; Morgan RD; Taylor SS
Genome Med; 2021 Sep; 13(1):140. PubMed ID: 34470661
[TBL] [Abstract] [Full Text] [Related]
12. [The composition of ascites lymphocytes in high-grade serous ovarian cancer and its correlation with clinical features].
He TH; Zhang J; Yin ZN; Zhang X; Li Y; Wu Y; Li HJ; Liang HM; Xue LX; Guo HY
Zhonghua Yi Xue Za Zhi; 2021 Aug; 101(30):2375-2381. PubMed ID: 34404130
[No Abstract] [Full Text] [Related]
13. Models for measuring metabolic chemical changes in the metastasis of high grade serous ovarian cancer: fallopian tube, ovary, and omentum.
Lusk H; Burdette JE; Sanchez LM
Mol Omics; 2021 Dec; 17(6):819-832. PubMed ID: 34338690
[TBL] [Abstract] [Full Text] [Related]
14. First case report of papillary thyroid carcinoma arising within a functional teratoma in Graves' disease patient.
Cheng CC; Ting-An ; Chang ; Yang WP
Gynecol Endocrinol; 2021 Oct; 37(10):955-958. PubMed ID: 34180765
[TBL] [Abstract] [Full Text] [Related]
15. Quantitative Mass Spectrometry-Based Proteomics for Biomarker Development in ovarian cancer.
Ryu J; Thomas SN
Molecules; 2021 May; 26(9):. PubMed ID: 34063568
[TBL] [Abstract] [Full Text] [Related]
16. A Distinctive Adnexal (Usually Paratubal) Neoplasm Often Associated With Peutz-Jeghers Syndrome and Characterized by STK11 Alterations (STK11 Adnexal Tumor): A Report of 22 Cases.
Bennett JA; Young RH; Howitt BE; Croce S; Wanjari P; Zhen C; Da Cruz Paula A; Meserve E; Schoolmeester JK; Westbom-Fremer S; Benzi E; Patil NM; Kooreman L; El-Bahrawy M; Zannoni GF; Krausz T; McCluggage WG; Weigelt B; Ritterhouse LL; Oliva E
Am J Surg Pathol; 2021 Aug; 45(8):1061-1074. PubMed ID: 33534223
[TBL] [Abstract] [Full Text] [Related]
17. ovarian Vein Thrombosis: A Narrative Review.
Riva N; Calleja-Agius J
Hamostaseologie; 2021 Aug; 41(4):257-266. PubMed ID: 33348392
[TBL] [Abstract] [Full Text] [Related]
18. Cytohistopathologic correlation of ovarian mesonephric-like carcinoma and female adnexal tumor of probable Wolffian origin.
Qazi M; Movahedi-Lankarani S; Wang BG
Diagn Cytopathol; 2021 Jun; 49(6):E207-E213. PubMed ID: 33296554
[TBL] [Abstract] [Full Text] [Related]
19. Updates in uterine artery embolization for leiomyomas.
Kim A; Arabkhazaeli M; Ulrich A; Lerner V; Shin JH
Curr Opin Obstet Gynecol; 2020 Aug; 32(4):269-276. PubMed ID: 32487798
[TBL] [Abstract] [Full Text] [Related]
20. Histological clues to the diagnosis of metastasis to the breast from extramammary malignancies.
Lee AHS; Hodi Z; Soomro I; Sovani V; Abbas A; Rakha E; Ellis IO
Histopathology; 2020 Aug; 77(2):303-313. PubMed ID: 32396659
[TBL] [Abstract] [Full Text] [Related]
[Next]
